Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | BRAF |
Variant | L597Q |
Impact List | missense |
Protein Effect | gain of function |
Gene Variant Descriptions | BRAF L597Q lies within the protein kinase domain of the Braf protein (UniProt.org). L597Q results in activation of Braf as indicated by increased phosphorylation of Mek and Erk in cell culture (PMID: 22798288) and induces cell proliferation and cell viability in culture (PMID: 29533785). |
Associated Drug Resistance | |
Category Variants Paths |
BRAF mutant BRAF act mut BRAF L597Q BRAF mutant BRAF L597X BRAF L597Q |
Transcript | NM_004333.6 |
gDNA | chr7:g.140753345A>T |
cDNA | c.1790T>A |
Protein | p.L597Q |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001378474.1 | chr7:g.140753345A>T | c.1790T>A | p.L597Q | RefSeq | GRCh38/hg38 |
NM_001378468.1 | chr7:g.140753345A>T | c.1790T>A | p.L597Q | RefSeq | GRCh38/hg38 |
NM_004333.6 | chr7:g.140753345A>T | c.1790T>A | p.L597Q | RefSeq | GRCh38/hg38 |
NM_004333 | chr7:g.140753345A>T | c.1790T>A | p.L597Q | RefSeq | GRCh38/hg38 |
NM_001354609.2 | chr7:g.140753345A>T | c.1790T>A | p.L597Q | RefSeq | GRCh38/hg38 |
NM_001378472.1 | chr7:g.140749333_140749334delTTinsCA | c.1789_1790delTTinsCA | p.L597Q | RefSeq | GRCh38/hg38 |
XM_005250045 | chr7:g.140753345A>T | c.1790T>A | p.L597Q | RefSeq | GRCh38/hg38 |
NM_001354609.1 | chr7:g.140753345A>T | c.1790T>A | p.L597Q | RefSeq | GRCh38/hg38 |
NM_004333.5 | chr7:g.140753345A>T | c.1790T>A | p.L597Q | RefSeq | GRCh38/hg38 |
NM_001378473.1 | chr7:g.140749333_140749334delTTinsCA | c.1789_1790delTTinsCA | p.L597Q | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03843775 | Phase Ib/II | Binimetinib + Encorafenib | A Study of Binimetinib and Encorafenib in Advanced BRAF Mutant Cancers | Completed | USA | 0 |